Investors are almost always on the lookout for biotech stocks and this morning it might be a wise move to take a closer look at the Curative Biotechnology Inc (OTCMKTS:CUBT) stock. Following a key announcement from the company yesterday, the Curative stock went up by 6% and thereby stretched its gains over the course of the past week to as much as 13%.
Yesterday the company announced that it signed an agreement with Atlantic BioTherapeutics for the purpose of expanding the license of IMT504 that had been announced previously. IMT504 is a novel immunotherapy that has been patented and the company is looking to expand the license in order to include the option of developing a COVID 19 vaccine.
It goes without saying that it was a significant announcement from Curative and one that led to considerable optimism among investors. In this regard, it should be kept in mind that initially Curative is going to be involved with the development of a vaccine that is going to help with tackling kidney failure.
It is clear that a lot is going on at Curative at this point and hence, it is a good time for investors to keep an eye on the news regarding the company.
